The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Peter Connick, Siddharthan Chandran, Michael A. Scott et al.|Trials|2011

Cited by 119